NANOVIRICIDES, INC.: 10-Q/A filed 2011-12-12

Name: NANOVIRICIDES, INC.: 10-Q/A filed 2011-12-12
Creator: NANOVIRICIDES, INC.

What NANOVIRICIDES, INC. reported in its quarterly report amendment filed 2011-12-12 (fiscal Q1 2012): 22 published measures, 71 facts as tagged in accession 0001144204-11-069272.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-Q/A (quarterly report amendment)
Filed: 2011-12-12
Fiscal period: fiscal Q1 2012
Accession: 0001144204-11-069272 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NANOVIRICIDES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-09-30	12,377,127	USD
At 2011-06-30	10,758,067	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2011-09-30	11,385,969	USD
At 2011-06-30	10,170,891	USD
At 2010-06-30	6,518,704	USD
At 2009-06-30	2,485,542	USD
At 2008-06-30	443,739	USD
At 2007-06-30	500,338	USD
At 2006-06-30	1,238,456	USD
At 2005-06-30	-66,005	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-09-30	10,879,319	USD
At 2011-06-30	9,224,023	USD
At 2010-09-30	7,677,554	USD
At 2010-06-30	6,955,733	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-1,139,976	USD	92
2005-05-12 to 2011-09-30	-24,356,885	USD	2333
2010-07-01 to 2011-06-30	-6,477,166	USD	365
2010-07-01 to 2010-09-30	-1,097,491	USD	92
2009-07-01 to 2010-06-30	-4,744,208	USD	365
2008-07-01 to 2009-06-30	-2,787,798	USD	365
2007-07-01 to 2008-06-30	-2,738,337	USD	366
2006-07-01 to 2007-06-30	-3,118,963	USD	365
2005-07-01 to 2006-06-30	-3,284,432	USD	365
2005-05-12 to 2005-06-30	-66,005	USD	50

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-676,273	USD	92
2005-05-12 to 2011-09-30	-16,620,488	USD	2333
2010-07-01 to 2010-09-30	-1,448,682	USD	92

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	23,352	USD	92
2005-05-12 to 2011-09-30	1,440,717	USD	2333
2010-07-01 to 2010-09-30	106,686	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	2,360,654	USD	92
2005-05-12 to 2011-09-30	29,370,012	USD	2333
2010-07-01 to 2010-09-30	2,295,000	USD	92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-29,085	USD	92
2005-05-12 to 2011-09-30	-1,870,205	USD	2333
2010-07-01 to 2010-09-30	-124,496	USD	92

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2011-07-01 to 2011-09-30	USD	92
2005-05-12 to 2011-09-30	USD	2333
2010-07-01 to 2010-09-30	USD	92

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-09-30	773,000	USD
At 2011-06-30	802,367	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-1,140,428	USD	92
2005-05-12 to 2011-09-30	23,866,366	USD	2333
2010-07-01 to 2010-09-30	-1,111,344	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-09-30	11,201,205	USD
At 2011-06-30	9,556,317	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-09-30	991,158	USD
At 2011-06-30	587,176	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	1,140,428	USD	92
2005-05-12 to 2011-09-30	23,866,366	USD	2333
2010-07-01 to 2010-09-30	1,111,344	USD	92

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	691,699	USD	92
2005-05-12 to 2011-09-30	14,936,917	USD	2333
2010-07-01 to 2010-09-30	750,128	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-09-30	145,763,702	shares
At 2011-06-30	143,548,394	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-09-30	35,588,822	USD
At 2011-06-30	33,235,990	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2011-09-30	402,922	USD
At 2011-06-30	399,383	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2011-09-30	93,919	USD
At 2011-06-30	27,173	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-1,139,976	USD	92
2005-05-12 to 2011-09-30	-24,356,885	USD	2333
2010-07-01 to 2010-09-30	-1,097,491	USD	92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	448,729	USD	92
2005-05-12 to 2011-09-30	9,350,291	USD	2333
2010-07-01 to 2010-09-30	361,216	USD	92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	452	USD	92
2005-05-12 to 2011-09-30	-490,519	USD	2333
2010-07-01 to 2010-09-30	13,853	USD	92

Inspect the source

Entity: NANOVIRICIDES, INC. / CIK 0001379006
Captured: 2026-09-20T07:58:03.748Z
SEC response SHA-256: 5d15adcbc42d7ac8bfebbf748da8ae31563dd5d02e790dc3e1b9bde076c805d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001379006.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))